Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04086654 Completed - Clinical trials for Post Traumatic Stress Disorder (PTSD)

Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD

Start date: March 2, 2020
Phase: N/A
Study type: Interventional

The aim of the project is to evaluate the psychometric properties (e.g. validity, reliability) of the International Trauma Interview (ITI) - German version. The ITI is a structured clinical interview that corresponds to the ICD-11 criteria for diagnosing both posttraumatic stress disorder (PTSD) and complex posttraumatic stress disorder (CPTSD). Eligible participants from psychiatric inpatient and outpatient facilities in Switzerland who have provided informed will complete various self-report measures about trauma-related mental health complaints. In addition, the ITI will be conducted by a trained clinician. Lastly, information from the medical chart will be further used for scientific purpose. The overall assessment will take approximately 1-2 hours to complete.

NCT ID: NCT04086602 Completed - Healthy Volunteers Clinical Trials

Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

Start date: September 13, 2019
Phase: Phase 1
Study type: Interventional

This is a first in human (FIH), single-centre, double -blind, randomised, cross-over, SAD followed by a MAD study of IZD334 conducted in healthy adult participants as well as an open-label cohort in adult patients with CAPS. The study is designed to evaluate the safety, tolerability, PK, PD, and food effect of IZD334 in healthy adult participants, and to evaluate the safety, tolerability, PK, PD, and preliminary clinical efficacy of IZD334 in adult patients with CAPS.

NCT ID: NCT04086095 Completed - Clinical trials for Respiratory Distress Syndrome in Premature Infant

Feasibility Study - Neofact

Start date: May 13, 2019
Phase: N/A
Study type: Interventional

For therapy of respiratory distress syndrome (RDS) in premature babies, there are several established options. An important therapeutic aspect is the tracheal administration of exogenous surfactant into the child's lung. In the recent years, several methods have been developed. The methods differ in the selected ventilation mode (intubation with mechanical ventilation vs. Continous Positive Airway Pressure (CPAP)-supported spontaneous breathing) and in the way in which the application of surfactant is technically conducted (via endotracheal tube, endotracheal catheter or nebulization). In selection of ventilation technique, there is an upcoming trend towards less invasive respiratory support via CPAP. While this may increase the rate of complications on the one side (i.e. pneumothorax), it shows much lower oxygen demand and a shorter need for mechanical ventilation on the other side. In the selection of the administration technique, different methods were repeatedly developed to adapt the surfactant administration to the CPAP therapy. In this study, a newly developed and in the European Community now certified (CE-Mark) application aid (Neofact) will be tested for the first time on preterm infants, to verify the feasibility.

NCT ID: NCT04085770 Completed - Clinical trials for Cardiac Valve Replacement Complication

Short Term Effect of Vitamin D Supplementation on the Clinical Outcomes in Patients Undergoing Valve Replacement Surgery

Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

This study evaluates the effect of Vitamin D supplementation on ICU and hospital LOS in patients undergoing valve replacement surgery. Half of the patients will receive Alfacalcidol, while the other half-the control group- will be exposed to the same environment without receiving alfacalcidol.

NCT ID: NCT04085744 Completed - Clinical trials for Intubation Complication

A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff

LA-STEROID
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

This study aims to compare effects of two different agents on complications due to tracheal tube cuff in pediatric patients. Sore throat, hoarseness, laryngospasm, bronchospasm are the main complications.

NCT ID: NCT04085601 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With PNH

Start date: August 27, 2019
Phase: Phase 3
Study type: Interventional

Evaluation of the Efficacy and Safety of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria .

NCT ID: NCT04085302 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

TARA Working Prototype Engagement Evaluation: Feasibility Study

Start date: September 26, 2019
Phase: N/A
Study type: Interventional

TARA is a Digital Behaviour Change Intervention (DBCI) for individuals with Chronic Obstructive Pulmonary Disease (COPD)(IwCOPD), which has been designed using a Human-Centred Design (HCD) methodology. HCD involves, among other elements, members of the target audience in evaluations at multiple stages within the design process. This feasibility study is primarily designed to assess the acceptability of the DBCI test asset to the target audience. Acceptability as defined for the purpose of this study includes usability of the system, and perceived value and desirability to the end-user audience. As such, engagement in this context is deemed to mean the degree to which the test asset provides a usable, acceptable, desirable and valuable experience to its users during a time-limited trial.

NCT ID: NCT04085224 Completed - Clinical trials for Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

Start date: September 10, 2019
Phase: Phase 1
Study type: Interventional

A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in Healthy Volunteers

NCT ID: NCT04085146 Completed - Clinical trials for Pulmonary Atelectasis, Postoperative

Individual Optimal Positive End-expiratory Pressure During Robot-assisted Laparoscopic Radical Prostatectomy

Start date: November 19, 2019
Phase: N/A
Study type: Interventional

During robot-assisted radical prostatectomy, pneumoperitoneum with Trendelenburg position is used. However, perioperative atelectasis and respiratory complications may occur with high incidence due to general anesthesia and carbon dioxide pneumoperitoneum. Intraoperative ventilatory strategy to address these issues include intraoperative recruitment maneuver and positive end-expiratory pressure (PEEP). Recently, individualized optimal PEEP with minimal driving pressure or maximal respiratory compliance was reported to reduce respiratory complications after general anesthesia. A recent version of general anesthesia ventilator provides a stepwise procedure of determining optimal PEEP by calculating respiratory compliance. We investigated whether the application of individualized optimal PEEP could reduce the incidence of atelectasis and respiratory complications after robot-assisted laparoscopic radical prostatectomy compared to uniform PEEP.

NCT ID: NCT04084652 Completed - Clinical trials for Anabolic Response to Mycoprotein and Micronutrient Ingeston

Mycoprotein and Muscle Protein Synthetic Response

PIMP
Start date: April 15, 2019
Phase: N/A
Study type: Interventional

Dietary protein is vital for the preservation of health and optimal adaptation to training. However, traditional animal proteins come with a number of economic, environmental, and ethical issues. Accordingly, there is a need to develop an understanding of the utility of more sustainable non-animal derived dietary proteins to support our nutrition. Mycoprotein, produced by Quorn Foods™, has recently been shown to stimulate a greater anabolic response within skeletal muscle compared with milk protein, suggesting its utility within sports nutrition. However, it is unclear what accounted for the greater anabolic response of mycoprotein. One explanation could be the non-protein nutrients contained within mycoprotein (e.g. fibre, carbohydrate, fat or micronutrients). Therefore, the present study will compare the muscle anabolic response between mycoprotein (MYC) as a whole food and the protein isolated from mycoprotein (PIM).